The recommended test panel comprises antithrombin, protein C, protein S, Factor V Leiden, and the FII G20210A mutation, with antiphospholipid antibodies as the only marker for acquired thrombophilia. This evidence concerns the gene F5 and Rare hereditary thrombophilia.